Abstract
We report a case of small gastric synovial sarcoma (SS) finally diagnosed after laparoscopic-endoscopic cooperative surgery (LECS). A 50 year-old male underwent medical examination for a chief complaint of epigastric pain. Endoscopic examination showed a 20 mm submucosal tumor (SMT) located in the anterior wall which extended to the lesser curvature of the middle stomach. The biopsy tissue did not yield a definitive diagnosis. During 6 months of follow-up for this lesion suspected to be an inflammatory tumor, neither the shape nor the size of the tumor changed. We performed LECS for both diagnosis and treatment. Histologically, the tumor was composed of fascicles of spindle cells. Immunohistochemically, the tumor cells were focally positive for epithelial membrane antigen, cytokeratin (AE1/AE3) and S100 protein, while being negative for desmin, α-smooth muscle actin, CD34, c-kit and DOG1. The expression of INI1 was reduced. Fluorescence in situ hybridization (FISH) detected SS18 rearrangement. The SMT was diagnosed as primary SS. A SMT measuring < 20 mm might be malignant potential tumor such as SS even if there are no typical malignant findings by endoscopy. Surgical resection should be considered for SMT measuring < 20 mm with atypical findings even in the absence of definitive high-risk features.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Synovial sarcoma (SS) is one of the malignant soft-tissue tumors, accounting for 10% of soft tissue sarcomas [1]. There are three main histologic subtypes of synovial sarcoma: the monophasic type composed of spindle cells (50–60%), the biphasic type composed of both epithelial and spindle cells (20–30%), and the poorly differentiated type (15–20%) [2, 3]. SS is characterized by the translocation t(X;18) (p11;q11) and subsequent formation of the SS18:SSX fusion genes [4]. Reportedly, SS usually arises in the extremities intimately related to tendons and bursal structures of large joints [5,6,7]. Gastric SS is rare although some SSs originating from the digestive tract have recently been reported. There have been, to date, only 49 such cases in the English literature. We herein present a patient with a primary gastric SS followed-up under a suspected diagnosis of inflammatory tumor with periodic endoscopic inspection.
Case report
A 50 year-old male had epigastric pain. Endoscopic examination showed a 20 mm elevated lesion from the anterior wall to the lesser curvature of the middle stomach. The tumor was mostly coated with intact mucosa and there was a slight reddish depression at the top of the tumor (Fig. 1A). After tissue biopsy, tumor shrinkage was seen with a central depression (Fig. 1B). Heterogeneous lesion was observed in the third layer by endoscopic ultrasound (EUS). The tumor had a mainly hypo-echoic appearance and was 11 × 5 mm in size, with a slender but distorted shape (Fig. 1C). Abdominal computed tomography demonstrated a high-attenuating nodule confined to the area from the anterior wall to the lesser curvature of the middle stomach. There were no findings of metastasis nor any evidence of another possible primary site. There were no relevant findings resulted from endoscopy or other examinations. Endoscopic biopsy revealed a small number of non-pleomorphic spindle cells. Immunohistochemically, the tumor cells were focally positive for epithelial membrane antigen (EMA) and negative for cytokeratin (AE1/AE3), S100 protein, desmin, α-smooth muscle actin (SMA), CD34, c-kit and DOG1. The findings were not considered to be diagnostic of malignancy, including gastrointestinal stromal tumors; however, the biopsy tissue did not yield a definitive diagnosis. The patient was closely followed-up under a suspected diagnosis of inflammatory tumor with repeated endoscopy every 3 months. Six months after the initial endoscopy, the biopsy scar at the tumor site was covered with regenerated epithelium. There were essentially no changes in the form or the size of the tumor (Fig. 1D). We decided to perform LECS both for diagnosis and treatment.
A total of 5 ports were placed in the abdominal wall. On entering the peritoneal cavity, the tumor did not show any macroscopic serosal change. By endoscopic procedure, the marking dots were made around the tumor with the distal tip of a needle knife. Next, a small initial incision was made with a needle knife and the tip of the insulation-tipped diathermic electrosurgical (IT) knife was inserted into the submucosal layer. Then, a semicircular incision was made using the IT knife and an artificial perforation was created with the needle knife. Finally, the full-thickness incision was made laparoscopically including the marking points. The defect of the gastric wall was closed with the linear stapler.
A flat elevated lesion was observed in the resected specimen. The tumor was 12 × 8 × 2 mm in size (Fig. 2). Histologically, the tumor was composed of intersecting fascicles of long spindle cells. These cells were monotonous with indistinct cytoplasm and fusiform to ovoid nucleus (Fig. 3A). Immunohistochemically, the tumor cells were focally positive for EMA (Fig. 3B), cytokeratin (AE1/AE3) and S100 protein. They were negative for desmin, αSMA, CD34, c-kit and DOG1. The expression of INI1 was reduced (Fig. 3C). Fluorescence in situ hybridization (FISH) detected SS18 rearrangement (Fig. 3D). The final diagnosis of SS was confirmed based on these findings.
Discussion
SMT measuring < 20 mm could be followed up by endoscopy or EUS once or twice a year if there are no high-risk features [8]. In this case, size of the tumor was just 20 mm and no remarkable high-risk features were observed by initial endoscopy. On biopsy, we could not confirm the diagnosis of sarcoma because the number of sampled tumor cells on initial biopsy showed relatively bland nuclei and lacked significant atypia, necrosis or mitotic activity. However, we did not deny malignant tumor completely because a sufficient amount of specimen could not be secured. Therefore, we decided to have a close follow-up of every three months. Although the lesion had been suspected to be an inflammatory tumor, the tumor did not morphologically alter and shrinkage of the tumor was not observed half a year later. We decided to perform tumor resection by LECS for purpose of diagnosis and treatment. Gastric SMT < 20 mm with high-risk features including irregular borders, ulceration and/or growth during endoscopic follow up are encouraged to undergo surgical resection because of a potential of high-risk GIST and/or malignant SMT [9]. Gastric SS is likely to involve the mucosal and submucosal layers [10]. The infiltrating pattern of SS in the mucosa is supposed to be different from that of GIST [11]. In previous report, even a 6 mm SS showed ulceration on the surface of the tumor [12]. Other specific endoscopic findings of gastric SS are polypoid [13] or central depression [14]. SMT measuring < 20 mm with atypical findings such as polypoid or central depression has a potential of SS. Therefore, surgical resection should be considered even in the absence of definitive high-risk features. The tumor was confirmed as SS based on histological analysis. In this case, no typical high-risk features were seen by initial endoscopy. The findings of depression at the top of the tumor would be a prodromal finding of high-risk features in consideration of the result of pathologic diagnosis. Primary gastric SS often involves the mucosal layer and exposes to the mucosal surface. On the other hand, GIST is often a well-circumscribed lesion and rarely infiltrates into the lamina propria [15].
In the resected specimen, intersecting fascicular proliferation of monotonous spindle cells in the present case was typical of monophasic SS. The immunophenotype was also classic, including EMA reactivity [16] and reduced expression of INI1. The latter finding is reported to be highly sensitive and specific for SS [17]. It is noteworthy that the immunonegativities for c-kit and DOG1 in the present case were not consistent with GIST. Molecular analysis is useful for the diagnosis of SS, because SS18-SSX fusion is pathognomonic of SS [18, 19]. For the detection of this fusion, FISH or reverse-transcription-polymerase chain reaction is frequently applied to paraffin sections [20]. In this case, we identified SS18 rearrangement by FISH.
There is no consensus on the optimal therapeutic strategy for primary gastric SS. Surgical strategies, including the surgical approach and extent of lymph node dissection (LND) or the necessity for subsequent chemotherapy, are still under debate. In this case, the SS was relatively smaller than those described in previous studies [21, 22] and no lymph node metastasis was observed on preoperative computed tomography. Therefore, we performed wedge resection by LECS without LND. Almost all of the recurrences have occurred to patients with large tumors of 50 mm or more [21,22,23,24,25]. However, a 49 year-old male underwent segmental gastrectomy for a 20-mm gastric SS and developed omental metastasis 13 months later and died in 29 months after the surgery [21]. Even a small tumor may have a risk of recurrence in patients with primary gastric SS. In the resected specimen, the gastric SS was 12 mm in size. The SS was relatively small and completely resected by LECS. We did not consider additional surgery for lymphadenectomy after LECS, although the role of lymphadenectomy in the treatment of soft tissue sarcoma has been debated. SS is characterized by less lymph node metastasis than other soft tissue sarcomas. The proportion of patients with nodal metastasis among the patients with SS was 4.2% based on the SEER database [26]. In our case, the size of the tumor was small and enlarged lymph nodes were not observed in preoperative CT and intraoperative findings. Our patient received closed follow-up without adjuvant chemotherapy and had no recurrence after 5 year-follow up.
In conclusion, a SMT measuring < 20 mm might be malignant potential tumor such as SS even if there were no typical high-risk features by endoscopy. Surgical resection should be considered for SMT measuring < 20 mm with atypical findings even in the absence of definitive high-risk features.
References
Mastrangelo G, Coindre JM, Ducimetiere F, et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer. 2012;118:5339–48.
Murphey MD, Gibson MS, Jennings BT, et al. From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics. 2006;26:1543–65.
Bakri A, Shinagare AB, Krajewski KM, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199:W208–15.
Banito A, Li X, Laporte AN, et al. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC11 to Drive Synovial Sarcoma. Cancer Cell. 2018;34:346–8.
C F, DRH dB, A GVk. Synovial sarcoma. In: Fletcher CDM, Unni KK, Mertens F, editors. WHO Classification of Tumours. Tumours of Soft Tissue and Bone. 2002; Lyon, France: IARC Press:200-4.
Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 1995;164:129–34.
Mankin HJ, Hornicek FJ. Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control. 2005;12:5–21.
Nishida T, Goto O, Raut CP, et al. Diagnostic and treatment strategy for small gastrointestinal stromal tumors. Cancer. 2016;122:3110–8.
Nishida T, Kawai N, Yamaguchi S, et al. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc. 2013;25:479–89.
Kinowaki Y, Abe S, Abe S, et al. Synovial sarcoma of the stomach: a case report and a systematic review of literature. Clin J Gastroenterol. 2021;14:1020–6.
Shibata R, Morishita M, Koreeda N, et al. Primary gastric synovial sarcoma resected by laparoscopic endoscopic cooperative surgery of the stomach: a case report. Surg Case Rep. 2021;7:225.
Yoshiyasu K, Kono H, Hojo Y, et al. A minute primary gastric synovial sarcoma with ulcer: a case report. Diagn Pathol. 2021;16:115.
Wang CC, Wu MC, Lin MT, et al. Primary gastric synovial sarcoma. J Formos Med Assoc. 2012;111:516–20.
So IT, Cho KB, Lee JY, et al. A primary gastric synovial sarcoma: a case report and literature review. Medicine (Baltimore). 2017;96: e8904.
Sahara S, Otsuki Y, Egawa Y, et al. Primary synovial sarcoma of the stomach—a case report and review of the literature. Pathol Res Pract. 2013;209:745–50.
Torres Rivas HE, Fernandez S, Fresno MF. Primary gastric synovial sarcoma. Pathology. 2014;46:253–6.
Ito J, Asano N, Kawai A, et al. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study. Hum Pathol. 2016;47:32–7.
Limon J, Dal Cin P, Sandberg AA. Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11). Cancer Genet Cytogenet. 1986;23:87–91.
Turc-Carel C, Dal Cin P, Limon J, et al. Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet. 1986;23:93.
Amary MF, Berisha F, Bernardi Fdel C, et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol. 2007;20:482–96.
Makhlouf HR, Ahrens W, Agarwal B, et al. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Am J Surg Pathol. 2008;32:275–81.
Romeo S, Rossi S, Acosta Marin M, et al. Primary Synovial Sarcoma (SS) of the digestive system: a molecular and clinicopathological study of fifteen cases. Clin Sarcoma Res. 2015;5:7.
Wong NA, Campbell F, Shepherd NA. Abdominal monophasic synovial sarcoma is a morphological and immunohistochemical mimic of gastrointestinal stromal tumour. Histopathology. 2015;66:974–81.
Hu S, Wong K, Ramesh KH, et al. Diffuse, aggressive metastatic progression after minimally invasive local resection of primary gastric synovial sarcoma: a case report and systematic review of the literature. J Gastrointest Cancer. 2019;50:116–22.
Billings SD, Meisner LF, Cummings OW, et al. Synovial sarcoma of the upper digestive tract: a report of two cases with demonstration of the X;18 translocation by fluorescence in situ hybridization. Mod Pathol. 2000;13:68–76.
Jacobs AJ, Morris CD, Levin AS. Synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas. Clin Orthop Relat Res. 2018;476:589–98.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest for this article.
Human rights
All procedures followed have been performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.
Informed consent
This study does not contain identifying information about the patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sato, Y., Morita, S., Yoshida, A. et al. Small gastric synovial sarcoma diagnosed and treatment by laparoscopic–endoscopic cooperative surgery: a case report. Clin J Gastroenterol 17, 18–22 (2024). https://doi.org/10.1007/s12328-023-01882-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-023-01882-y